Submitted:
03 July 2024
Posted:
03 July 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Reagents
2.2. Animals and Grouping
2.3. Establishment of Animal Models
2.4. Observation Indicators
2.4.1. Changes in HR and Heart Rhythm
2.4.2. Record Dosage (g), the Number of Injections, and Hematuria Status
2.4.3. Hematoxylin and Eosin(HE) Staining
2.4.4. Detection of mRNA for Sodium Voltage-Gated Channel Type Vα (SCN5A), Hyperpolarization-Activated Cyclic Nucleotide-Gated Cation Channel 4 (HCN4), Potassium Voltage-Gated Channel Eag-Related Subfamily H2 (KCNH2), Potassium Voltage-Gated Channel KQT-like Subfamily 1 (KCNQ1), and Large-Conductance Calcium-Activated Potassium Channel Ma1 (KCNMA1)
2.4.5. Western Blotting
2.4.6. Quantitative Experiment of Calcium Ions
2.5. Statistical Analysis
3. Results
3.1. Model Establishment Rate
3.2. HR Changes
3.3. Changes in Cardiac Rhythm
3.4. Multivariate Analysis Related to Model Establishment
3.5. Pathological Changes
3.6. Changes in Membrane Ion Channel Gene Transcription
3.7. Changes in HCN4 Protein Expression
3.8. Changes in Calcium Ion Content
4. Discussion
5. Conclusion
Author Contributions
Acknowledgments
Declaration of Competing Interest
References
- Zhang H, Li L, Hao M, et al. Yixin-Fumai granules improve sick sinus syndrome in aging mice through Nrf-2/HO-1 pathway: A new target for sick sinus syndrome. J Ethnopharmacol, 2021, 277: 114254. [CrossRef]
- Guo J H(Chief Editor), Ma X R, Xu Y, Wu X, et al. (Editors). Electrocardiography. Beijing: People’s Medical Publishing Hous, Beijing, China, 2002; 377-400.
- Mu Y G(Editor), Guo J H(Main Reviewer). Exquisite Explanations of Clinical Electrocardiogram. Beijing: Peking University Medical Press, Beijing, China, 2012; 1-16.
- Bodin A, Bisson A, Gaborit C, et al. Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions. Stroke, 2020, 51(6): 1674-1681. [CrossRef]
- Jensen P N, Gronroos N N, Chen L Y, et al. Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol, 2014, 64(6): 531-8. [CrossRef]
- Hawks M K, Paul M L B, Malu O O. Sinus Node Dysfunction. Am Fam Physician, 2021, 104(2): 179-185.
- Zhang W, Zhu B, Ren J, et al. Two methods for modeling of sick sinus syndrome in rats: Ischemia reperfusion and sodium hydroxide induced injury. Biomedicine & Pharmacotherapy, 2019, 111: 778-784. [CrossRef]
- Geng N, Jiang N, Peng C, et al. Sodium Hydroxide Pinpoint Pressing Permeation Method for the Animal Modeling of Sick Sinus Syndrome. Int Heart J, 2015, 56(4): 439-43. [CrossRef]
- Jiang L, X. Comparative study on the models of sick sinus syndrome in rats. Master’s thesis, Zunyi Medical University, Guizhou Province, China, 2021.
- Liu R X, Wang Y L, Li H B, et al. Comparative study between original and traditional method in establishing a chronic sinus node damage model in rabbits. J Appl Physiol (1985), 2012, 113(11): 1802-8. [CrossRef]
- Bi L, S. Effects of different modeling methods of sick sinus syndrome on the function of pacing-related ion channels and the therapeutic effect of Qiangxin Fumai granul. Master’s thesis, Xinxiang Medical University, Henan Province, China, 2022.
- Hong L, Juanjuan Z, Xiaoxiang Z, et al. Therapeutical effect of Radix Aconiti and Astragalus extracts on models of experimental bradycardia animal. Pak J Pharm Sci, 2014, 27(3): 439-44.
- Hasan W, Smith P G. Modulation of rat parasympathetic cardiac ganglion phenotype and NGF synthesis by adrenergic nerves. Auton Neurosci, 2009, 145(1-2): 17-26. [CrossRef]
- Herrmann S, Fabritz L, Layh B, et al. Insights into sick sinus syndrome from an inducible mouse model. Cardiovasc Res, 2011, 90(1): 38-48. [CrossRef]
- Zhong H, Wang T, Lian G, et al. TRPM7 regulates angiotensin II-induced sinoatrial node fibrosis in sick sinus syndrome rats by mediating Smad signaling. Heart Vessels, 2018, 33(9): 1094-1105. [CrossRef]
- Guo Y C, Cui C C, Huang Q S. Classification and Long-Term Follow-Up of Sick Sinus Syndrome. Pacing and Cardiac, 1992(02): 92-93.
- Thorolfsdottir R B, Sveinbjornsson G, Aegisdottir H M, et al. Genetic insight into sick sinus syndrome. Eur Heart J, 2021, 42(20): 1959-1971. [CrossRef]
- Bai X, Wang K, Yuan Y, et al. Mechanism underlying impaired cardiac pacemaking rhythm during ischemia: A simulation study. Chaos, 2017, 27(9): 093934. [CrossRef]
- Monfredi O, Dobrzynski H, Mondal T, et al. The anatomy and physiology of the sinoatrial node--a contemporary review. Pacing Clin Electrophysiol, 2010, 33(11): 1392-406. [CrossRef]
- Liu Y Q, Peng R Y, Gao Y B, et al. Quantitative observation of the anatomical location and histological characteristics of the sinoatrial node in adult rats. Chinese Journal of Stereology and Image Analysis, 2013, 18(01): 60-66.
- Yin Y Q, Zhong Y, Zhu Y, et al. Changes in gap junction proteins Connexin30.2 and Connexin40 expression in the sinoatrial node of rats with dexmedetomidine-induced sinus bradycardia. Braz J Anesthesiol, 2022, 72(6): 768-773. [CrossRef]
- Logantha S, Kharche S R, Zhang Y, et al. Sinus node-like pacemaker mechanisms regulate ectopic pacemaker activity in the adult rat atrioventricular ring. Sci Rep, 2019, 9(1): 11781. [CrossRef]
- Verkerk A O, Wilders R. The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data. Biomedicines, 2023, 11(9). [CrossRef]
- Ren L, Gopireddy R R, Perkins G, et al. Disruption of mitochondria-sarcoplasmic reticulum microdomain connectomics contributes to sinus node dysfunction in heart failure. Proc Natl Acad Sci U S A, 2022, 119(36): e2206708119. [CrossRef]
- Liu, Y. Study on the Mechanism of Shenxian Shengmai Oral Liquid in Treating Sick Sinus Syndrome Based on Network Pharmacology. Doctoral thesis, Liaoning University of Traditional Chinese Medicine, Liaoning Province, China, 2022.
- Lang D, Glukhov A V. Cellular and Molecular Mechanisms of Functional Hierarchy of Pacemaker Clusters in the Sinoatrial Node: New Insights into Sick Sinus Syndrome. J Cardiovasc Dev Dis, 2021, 8(4). [CrossRef]
- Wirth A N, Tsutsui K, Maltsev V A, et al. Adenosine reduces sinoatrial node cell action potential firing rate by uncoupling its membrane and calcium clocks. Front Physiol, 2022, 13: 977807. [CrossRef]
- Tagirova Sirenko S, Tsutsui K, Tarasov K V, et al. Self-Similar Synchronization of Calcium and Membrane Potential Transitions During Action Potential Cycles Predict Heart Rate Across Species. JACC Clin Electrophysiol, 2021, 7(11): 1331-1344. [CrossRef]
- Zhang X, Zhou Y, Chang X, et al. Tongyang Huoxue decoction (TYHX) ameliorating hypoxia/reoxygenation-induced disequilibrium of calcium homeostasis via regulating β-tubulin in rabbit sinoatrial node cells. J Ethnopharmacol, 2024, 318(Pt B): 117006. [CrossRef]
- Huang X, Yang P, Yang Z, et al. Age-associated expression of HCN channel isoforms in rat sinoatrial node. Exp Biol Med (Maywood), 2016, 241(3): 331-9. [CrossRef]
- Machida N, Hirakawa A. The Anatomical Substrate for Sick Sinus Syndrome in Dogs. J Comp Pathol, 2021, 189: 125-134. [CrossRef]
- Yan J, Li H, Bu H, et al. Aging-associated sinus arrest and sick sinus syndrome in adult zebrafish. PLoS One, 2020, 15(5): e0232457. [CrossRef]




| Type | Lesion Range | ECG Manifestations |
|---|---|---|
| type A (simple SSS type) |
confined to the SAN | sinus bradycardia, sinus arrest, and sinoatrial block, without rapid arrhythmias and atrioventricular(AV) or bundle branch conduction block |
| type B (bradycardia-tachycardia syndrome type) |
in addition to involving the SAN, atrial or perinodal area is also affected. | sinus bradycardia, sinus arrest, and sinoatrial block, by atrial tachycardia, paroxysmal atrial fibrillation, and supraventricular tachycardia. |
| type C (double node lesion type or total conduction system lesion) |
involving the SAN and atrioventricular node(AVN), with intra-atrial or bundle branch conduction block | sinus bradycardia, sinoatrial block accompanied by AV conduction block or bundle branch conduction block |
| Group | Pre-Molding(n) | 1 hour Post-Molding | 1 week Post-Molding(n) | 2 weeks Post-Molding |
|---|---|---|---|---|
| sham | 12 | 12 | 12 | 9 |
| 3%NaOH | 30 | 26 | 26 | 23 |
| 10%NaOH | 30 | 17 | 17 | 14 |
| Variable | 3%NaOH (n=31) | 10%NaOH (n=31) | Z/X2 | P-Value |
|---|---|---|---|---|
| Amount of NaOH(g) | 0.011(0.008,0.012) | 0.009(0.007,0.012) | Z=0.97 | >0.05 |
| number of injections(n) | 4.5(4.0,6.0) | 2.5(2.0,3.0) | Z=5.09 | <0.001 |
| hematuria (n%) | 26(86.7) | 18(60) | X2=5.46 | <0.05 |
| Variable | B Value | Standard Error | Wald X2 | P-Value | OR | 95%CI |
|---|---|---|---|---|---|---|
| number of injections | 0.46 | 0.27 | 2.98 | >0.05 | 1.58 | 0.94-2.66 |
| hematuria | 3.73 | 0.89 | 17.44 | <0.001 | 41.46 | 7.22-238.15 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).